Literature DB >> 22211093

Early biventricular molecular responses to an acute myocardial infarction.

Cenk Erdal1, Gökhan Karakülah, Emel Fermancı, Imge Kunter, Erdem Silistreli, Tülay Canda, Esra Erdal, Hasan Hepaguslar.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) remains as one of the most common lethal diseases in the world and therefore it is necessary to understand its effect on molecular basis. Genome-wide microarray analysis provides us to predict potential biomarkers and signaling pathways for this purpose.
OBJECTIVES: The aim of this study is to understand the molecular basis of the immediate right ventricular cellular response to left ventricular AMI.
MATERIAL AND METHODS: A rat model of left anterior descending coronary artery ligation was used to assess the effect of left ventricular AMI on both the right ventricle as a remote zone and the left ventricle as an ischemic/infarct zone. Microarray technology was applied to detect the gene expression. Gene Ontology and KEGG pathways analysis were done to identify effected pathways and related genes.
RESULTS: We found that immune response, cell chemotaxis, inflammation, cytoskeleton organization are significantly deregulated in ischemic zone as early response within 30 min. Unexpectedly, there were several affected signaling pathways such as cell chemotaxis, regulation of endothelial cell proliferation, and regulation of caveolea regulation of anti-apoptosis, regulation of cytoskeleton organization and cell adhesion on the remote zone in the right ventricle.
CONCLUSION: This data demonstrates that there is an immediate molecular response in both ventricles after an AMI. Although the ischemia did not histologically involve the right ventricle; there is a clear molecular response to the infarct in the left ventricle. This provides us new insights to understand molecular mechanisms behind AMI and to find more effective drug targets.

Entities:  

Keywords:  Acute myocardial infarction; molecular response

Mesh:

Substances:

Year:  2011        PMID: 22211093      PMCID: PMC3245415          DOI: 10.7150/ijms.9.74

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


  29 in total

1.  Altered patterns of gene expression in response to myocardial infarction.

Authors:  L W Stanton; L J Garrard; D Damm; B L Garrick; A Lam; A M Kapoun; Q Zheng; A A Protter; G F Schreiner; R T White
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

2.  Cardioprotective effects of hydrogen sulfide.

Authors:  Gábor Szabó; Gábor Veres; Tamás Radovits; Domokos Gero; Katalin Módis; Christiane Miesel-Gröschel; Ferenc Horkay; Matthias Karck; Csaba Szabó
Journal:  Nitric Oxide       Date:  2010-11-19       Impact factor: 4.427

Review 3.  Molecular and cellular mechanisms of myocardial failure.

Authors:  W S Colucci
Journal:  Am J Cardiol       Date:  1997-12-04       Impact factor: 2.778

4.  Molecular dynamics of the compensatory response to myocardial infarct.

Authors:  W A LaFramboise; K L Bombach; R J Dhir; N Muha; R F Cullen; A R Pogozelski; D Turk; J D George; R D Guthrie; J A Magovern
Journal:  J Mol Cell Cardiol       Date:  2004-12-08       Impact factor: 5.000

5.  Molecular composition of the intercalated disc in a spontaneous canine animal model of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Eva M Oxford; Melanie Everitt; Wanda Coombs; Philip R Fox; Marc Kraus; Anna R M Gelzer; Jeffrey Saffitz; Steven M Taffet; N Sydney Moïse; Mario Delmar
Journal:  Heart Rhythm       Date:  2007-06-08       Impact factor: 6.343

6.  The timing of development and subsequent clinical course of heart failure after a myocardial infarction.

Authors:  Azam Torabi; John G F Cleland; Nasrin K Khan; Puan H Loh; Andrew L Clark; Farqad Alamgir; John L Caplin; Alan S Rigby; Kevin Goode
Journal:  Eur Heart J       Date:  2008-03-19       Impact factor: 29.983

Review 7.  Animal models of arrhythmogenic cardiomyopathy.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Dis Model Mech       Date:  2009 Nov-Dec       Impact factor: 5.758

8.  Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.

Authors:  Yasuo M Tsutsumi; Yousuke T Horikawa; Michelle M Jennings; Michael W Kidd; Ingrid R Niesman; Utako Yokoyama; Brian P Head; Yasuko Hagiwara; Yoshihiro Ishikawa; Atsushi Miyanohara; Piyush M Patel; Paul A Insel; Hemal H Patel; David M Roth
Journal:  Circulation       Date:  2008-10-20       Impact factor: 29.690

9.  Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model.

Authors:  Sumeet S Chugh; Stacey Whitesel; Mark Turner; Charles T Roberts; Srinivasa R Nagalla
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

10.  Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease.

Authors:  Juan A Rodriguez-Feo; Willem E Hellings; Frans L Moll; Jean-Paul P M De Vries; Ben J van Middelaar; Ale Algra; Joost Sluijter; Evelyn Velema; Theo van den Broek; William C Sessa; Dominique P V De Kleijn; Gerard Pasterkamp
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more
  3 in total

1.  MRTF-A alleviates myocardial ischemia reperfusion injury by inhibiting the inflammatory response and inducing autophagy.

Authors:  Ze Zhong; Xiu-Ying Luo; Peng Xiang; Hong-Hui Ji; Xin-Dong Wu; Ai-Guo Chong; Xin-Yang Hu; Xiao-Lu Cao
Journal:  Mol Cell Biochem       Date:  2022-07-12       Impact factor: 3.842

2.  Differential gene expression profiles in peripheral blood in Northeast Chinese Han people with acute myocardial infarction.

Authors:  Lin Fan; Heyu Meng; Xudong Guo; Xiangdong Li; Fanbo Meng
Journal:  Genet Mol Biol       Date:  2018 Jan-Mar       Impact factor: 1.771

3.  SERPINB1 overexpression protects myocardial damage induced by acute myocardial infarction through AMPK/mTOR pathway.

Authors:  Hongliang Wang; Jun Hua; Shiyuan Chen; Ying Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-03-15       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.